- Truist analyst Michael Ciarmoli initiated coverage of Howmet Aerospace Inc (NYSE:HWM) with a Buy rating and a price target of $41, implying an upside of 31.5%.
- The analyst says that HWM is a unique and differentiated asset in the aerospace supply chain.
- Ciarmoli notes that Howmet can benefit from growing aircraft production rates, share gains in the titanium aerospace market, and an easing supply chain in the transportation market.
- Price Action: HWM shares are trading higher by 0.27% at $31.18 on the last check Wednesday.
Cantex Pharmaceuticals Obtains Exclusive Worldwide Rights To Intellectual Property From Georgetown University For Azeliragon As A Potential Treatment Of Cancer-related Cognitive Decline; NOTE: Azeliragon Was Discovered By vTv And Licensed To Cantex Pha…
Cantex to Expand Collaboration with Georgetown's Lombardi Comprehensive Cancer Center
WESTON, Fla., June 1, 2023 /PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical
